BioE3 Policy: Biomanufacturing Push with States
Why in the news
DBT held talks with States on setting up biomanufacturing facilities under the BioE3 policy.
Key facts
- BioE3 was cleared by the Union Cabinet in August 2024.
- Biomanufacturing is industrial production of bio-based goods: chemicals, biopolymers, enzymes, smart proteins, functional foods, precision biotherapeutics and climate-resilient farming solutions.
- Most States have no separate biotech manufacturing policy; a Centre-State partnership is essential.
- DBT Secretary Rajesh Gokhale said such policies would help firms like Biocon emerge.
- Minister Jitendra Singh said early movers among States gain an edge.
Proposed steps
- State BioE3 cells and action plans
- Steering committees, working groups, nodal officers
- Bio-AI hubs, foundries, biomanufacturing hubs
Concerns
- States cited limited Central financial and strategic backing.
Exam angle
- Nodal department: DBT.
- Cabinet approval: August 2024.